BIOMAT Database Logo BIOMAT Database Logo

Knowledge, Attitude, and Management of General Dentist toward Medication-related Osteonecrosis of the Jaws. 2020

Nasser R Alqhtani, and Abdulrahman K Almalki, and Faisal A Zuhair, and Adel A Alenazi, and Abdullah Bin Nabhan, and Mana Alqahtani
Department of Oral and Maxillofacial Surgery and Diagnostic Science, College of Dentistry, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.

BACKGROUND Medication-related osteonecrosis of the jaw (MRONJ) is an intense negative drug response causing increasing bone destruction in the maxillofacial area of patients. OBJECTIVE To evaluate the knowledge and attitude of dental practitioner regarding risk factors of MRONJ in Saudi Arabia. METHODS A cross-sectional, questionnaire survey was carried out in King Khalid Hospital, Al-Kharj among dental practioners. RESULTS Approximately 60% of the practioners had a poor knowledge and there was a weak positive correlation with work experience. CONCLUSIONS Poor knowledge regarding the MRONJ invites a continuing dental education specially to focus on general practioners.

UI MeSH Term Description Entries

Related Publications

Nasser R Alqhtani, and Abdulrahman K Almalki, and Faisal A Zuhair, and Adel A Alenazi, and Abdullah Bin Nabhan, and Mana Alqahtani
Medication-Related Osteonecrosis of the Jaws.
August 2019, Journal of the National Cancer Institute. Monographs,
Nasser R Alqhtani, and Abdulrahman K Almalki, and Faisal A Zuhair, and Adel A Alenazi, and Abdullah Bin Nabhan, and Mana Alqahtani
Fluorescence-guided surgical management of medication-related osteonecrosis of the jaws.
December 2020, Photodiagnosis and photodynamic therapy,
Nasser R Alqhtani, and Abdulrahman K Almalki, and Faisal A Zuhair, and Adel A Alenazi, and Abdullah Bin Nabhan, and Mana Alqahtani
Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.
June 2021, Morphologie : bulletin de l'Association des anatomistes,
Nasser R Alqhtani, and Abdulrahman K Almalki, and Faisal A Zuhair, and Adel A Alenazi, and Abdullah Bin Nabhan, and Mana Alqahtani
Update on Medication Related Osteonecrosis of the Jaws.
April 2023, Delaware journal of public health,
Nasser R Alqhtani, and Abdulrahman K Almalki, and Faisal A Zuhair, and Adel A Alenazi, and Abdullah Bin Nabhan, and Mana Alqahtani
Awareness of medication related osteonecrosis of the jaws (MRONJ) amongst general dental practitioners.
January 2017, British dental journal,
Nasser R Alqhtani, and Abdulrahman K Almalki, and Faisal A Zuhair, and Adel A Alenazi, and Abdullah Bin Nabhan, and Mana Alqahtani
Osteoporosis treatment and medication-related osteonecrosis of the jaws.
April 2016, Australian prescriber,
Nasser R Alqhtani, and Abdulrahman K Almalki, and Faisal A Zuhair, and Adel A Alenazi, and Abdullah Bin Nabhan, and Mana Alqahtani
Nonsurgical Management of Medication-Related Osteonecrosis of the Jaws Using Local Wound Care.
November 2018, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons,
Nasser R Alqhtani, and Abdulrahman K Almalki, and Faisal A Zuhair, and Adel A Alenazi, and Abdullah Bin Nabhan, and Mana Alqahtani
Knowledge and attitude regarding bisphosphonates and related osteonecrosis among Turkish dentist: A cross sectional study.
October 2021, Nigerian journal of clinical practice,
Nasser R Alqhtani, and Abdulrahman K Almalki, and Faisal A Zuhair, and Adel A Alenazi, and Abdullah Bin Nabhan, and Mana Alqahtani
Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?
January 2016, Case reports in dentistry,
Nasser R Alqhtani, and Abdulrahman K Almalki, and Faisal A Zuhair, and Adel A Alenazi, and Abdullah Bin Nabhan, and Mana Alqahtani
Pain characteristics in medication-related osteonecrosis of the jaws.
February 2021, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
Copied contents to your clipboard!